I have a proven record in corporate transformation, governance and value creation. I’m passionate about enabling innovation-led companies to scale responsibly, build investor trust and deliver sustainable value. I am typically most impactful in 3 situations: (1) when investors assess life-science assets where execution risk is underestimated, (2) in post-transaction or transformation phase where organisations need stabilising governance to maintain speed and (3) together with science-driven leadership teams navigating scale and investor expectations. In a nutshell: I bring strategic clarity, capital market insight and board-level perspective to advance science into lasting enterprise value.
Get in Touch